Comparison of Standard Initial Dose and Reduced Initial Dose Regorafenib for Colorectal Cancer Patients: A Retrospective Cohort Study
京都大学 === 新制・課程博士 === 博士(医学) === 甲第23067号 === 医博第4694号 === 新制||医||1049(附属図書館) === 京都大学大学院医学研究科医学専攻 === (主査)教授 今中 雄一, 教授 武藤 学, 教授 妹尾 浩 === 学位規則第4条第1項該当 === Doctor of Medical Science === Kyoto University === DFAM...
Main Author: | Nakashima, Masayuki |
---|---|
Other Authors: | 中嶌, 雅之 |
Format: | Doctoral Thesis |
Language: | English |
Published: |
Kyoto University
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/2433/263528 |
Similar Items
-
The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice
by: Yoon SE, et al.
Published: (2018-12-01) -
The use of regorafenib in colorectal cancer
by: Marina I Sekacheva, et al.
Published: (2019-06-01) -
Effect of starting dose of regorafenib on overall survival of patients with metastatic colorectal cancer: a systematic review and meta-analysis
by: Mikhail Yu Fedyanin, et al.
Published: (2019-09-01) -
Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study
by: Yukinori Ozaki, et al.
Published: (2018-02-01) -
Efficacy of A Fluoropyrimidine plus Mitomycin C in Pretreated Patients with Metastatic Colorectal Cancer Eligible for Regorafenib: A Retrospective Study
by: Federica Martorana, et al.
Published: (2017-11-01)